Results 11 to 20 of about 63,942 (244)
Introdction: The Pan American Health Organization estimates that 2.0% of the world population should donate blood regularly. The Latin American and Caribbean countries collect blood equivalent to 1.5% of their population, what is below the recommended ...
Clayton Josef Thomaz Pinheiro +4 more
semanticscholar +2 more sources
A toxoplasmose, causada pelo protozoário Toxoplasma gondii, é considerada um problema de saúde pública, causando consequências graves em indivíduos imunocomprometidos e gestantes com infecção aguda, principalmente sobre a saúde do feto.
Ingrid Felix Ferreira Silva +2 more
semanticscholar +1 more source
Terapia da Covid-19 com anticorpos monoclonais
Em dezembro de 2019, na cidade de Wuhan, surgiu uma nova variante viral causadora de um surto de síndrome respiratória de origem desconhecida. Em paralelo a isto, foram desenvolvidas várias vacinas eficazes como também estão em andamento estudos de ...
G. Silva +4 more
semanticscholar +1 more source
Introdução: A utilização dos anticorpos monoclonais vem sendo incorporada aos protocolos de tratamento para câncer, uma vez comprovada sua eficácia.
Renan Martinelli Leonel +3 more
semanticscholar +1 more source
Ação bactericida de isoaglutininas ABO em diferentes diluições de anticorpos anti-ABO
Tendo em vista o grande polimorfismo dos sistemas de grupos sanguíneos e que uma das hipóteses para explicá-los seja a co-evolução com patógenos, esta pesquisa teve como objetivo avaliar a ação bactericida in vitro dos anticorpos anti-ABO sobre a ...
Naiara Merenciano Gomes +4 more
semanticscholar +1 more source
Background – The caninised monoclonal antibody lokivetmab (LKV), directed at interleukin (IL)‐31, is very effective at controlling pruritus in most dogs with atopic dermatitis (AD). However, evidence exists that IL‐31 is not required for the induction of acute allergic skin inflammation, which might explain why this treatment is less efficacious in ...
Chie Tamamoto‐Mochizuki +4 more
wiley +1 more source
Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis +6 more
wiley +1 more source
Abstract Through active surveillance and contact tracing from outpatients, we aimed to identify and characterize SARS‐CoV‐2 variants circulating in Porto Velho‐Rondônia, a city in the Brazilian Amazon. As part of a prospective cohort, we gathered information from 2,506 individuals among COVID‐19 patients and household contacts.
Gabriella S. Oliveira +15 more
wiley +1 more source
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel +4 more
wiley +1 more source
Immunopathogenesis of the feline atopic syndrome
Résumé Contexte Les maladies félines supposées d’origine allergique avec des phénotypes cliniques semblables, peuvent avoir de nombreuses pathogénies différentes sous jacentes. Le phénotype clinque, l’étiologie précise et l’immunopathogénie sous jacente doivent tous être considérés si des avancées veulent être faites dans ces domaines négligés de la ...
Richard Halliwell +3 more
wiley +1 more source

